Loading…
Tectonic Therapeutic, Inc. is projected to rise to $40.82 by 2027, a +34% move from its current price of $30.43. TECX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $29.53 | $30.46 | $31.41 | +0.09% |
| May 30 | $29.18 | $30.48 | $31.84 | +0.18% |
| May 31 | $28.93 | $30.51 | $32.18 | +0.26% |
| Jun 1 | $28.71 | $30.54 | $32.48 | +0.35% |
| Jun 2 | $28.53 | $30.56 | $32.74 | +0.44% |
| Jun 3 | $28.37 | $30.59 | $32.99 | +0.53% |
| Jun 4 | $28.22 | $30.62 | $33.22 | +0.61% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $28.22 | $30.62 | $33.22 | +0.61% |
| Week 2 | $27.45 | $30.81 | $34.57 | +1.23% |
| Week 3 | $26.92 | $30.99 | $35.69 | +1.86% |
| Week 4 | $26.50 | $31.19 | $36.70 | +2.48% |
| Week 5 | $26.15 | $31.38 | $37.65 | +3.11% |
| Week 6 | $25.86 | $31.57 | $38.54 | +3.75% |
| Week 7 | $25.61 | $31.76 | $39.40 | +4.38% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tectonic Therapeutic, Inc. is a biotechnology company that focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines.
The company is headquartered in Watertown, Massachusetts and operates in the Healthcare sector. Its work centers on GPCR modulation and biologic medicines, with TX45 as a lead program and TX2100 and other GPCR modulators in development.
This description reflects the company’s stated focus and headquarters as described in its profile.
TECX is a healthcare stock currently trading at $29.12 with a market capitalization of $549.47M, ranking 2969 by market cap.
The price outlook is bullish over the longer term, with a forecast path that envisions rising averages well into the 2030s and beyond, including multi-year gains from current levels.
The thirty-day range is $23.57 to $35.97, illustrating near-term price movement within a bullish longer-term trajectory. The current price and market position place TECX among mid-cap healthcare equities with substantial upside potential per the forecast series.
A major floor 38.2% below — a decisive break under it would weaken the trend.
The nearest floor, 11.7% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 17.9% above — clearing it would confirm fresh momentum.
Key TECX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TECX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $29.38 | Buy | $29.52 | Buy |
| MA 10 | $28.84 | Buy | $29.06 | Buy |
| MA 20 | $28.59 | Buy | $28.84 | Buy |
| MA 50 | $29.31 | Buy | $28.40 | Buy |
| MA 100 | $26.32 | Buy | $26.74 | Buy |
| MA 200 | $22.63 | Buy | $24.95 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.62 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 143.17 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.24 | Buy |
| ROC (12) | 4.93 | Buy |
| Bollinger %B (20,2) | 0.96 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.08 | Sell |
| Awesome (5,34) | 0.55 | Buy |
| Ultimate (7,14,28) | 68.21 | Neutral |
| Momentum (10) | 2.47 | Buy |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 30.06 | Buy |
| ADX (14) | 8.50 | Neutral |
| ATR (14) | 0.82 | Info |
Near-term technical picture is bullish, with sentiment labeled BULLISH.
RSI14 is 50, and the stock trades near the SMA50 of $29.42 while SMA200 sits at $22.55. Support is identified at $26.87 and resistance at $29.96.
The thirty-day range runs from $23.57 to $35.97, and annualized volatility stands at 60%, indicating meaningful near-term price fluctuation within a bullish longer-term context.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $18.80 | $30.43 | $44.47 | 0% | Neutral | |
| $31.98 | $40.82 | $55.44 | +34% | Bullish | |
| $40.87 | $53.82 | $76.04 | +77% | Bullish | |
| $51.45 | $69.54 | $101.36 | +129% | Bullish | |
| $61.81 | $85.52 | $127.96 | +181% | Bullish | |
| $75.29 | $106.39 | $162.90 | +250% | Bullish | |
| $75.95 | $109.48 | $171.12 | +260% | Bullish | |
| $80.06 | $117.60 | $187.27 | +286% | Bullish | |
| $94.61 | $141.47 | $229.18 | +365% | Bullish | |
| $108.14 | $164.50 | $270.78 | +441% | Bullish | |
| $168.42 | $277.13 | $487.59 | +811% | Bullish | |
| $388.22 | $733.08 | $1,420.80 | +23.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $18.80 | $30.43 | $35.83 | +0.00% |
| June 2026 | $26.88 | $31.65 | $38.22 | +4.01% |
| July 2026 | $27.72 | $32.96 | $40.41 | +4.14% |
| August 2026 | $27.17 | $32.55 | $40.37 | -1.25% |
| September 2026 | $26.94 | $32.47 | $40.66 | -0.22% |
| October 2026 | $28.09 | $34.05 | $43.00 | +4.86% |
| November 2026 | $28.65 | $34.90 | $44.40 | +2.49% |
| December 2026 | $28.36 | $34.71 | $44.47 | -0.54% |
Click any year to see its month-by-month TECX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The TECX price prediction for 2026 points to an average of $30.43 (low $18.80, high $44.47) — a potential gain of 0% on today's $30.43. A consolidation phase looks the most probable path here.
In 2027, TECX is projected to trade between $31.98 and $55.44, averaging $40.82 — a potential gain of +34% from today's $30.43. That is up +34% on the projected 2026 average. Momentum favours further upside here.
Tectonic Therapeutic, Inc.'s 2028 outlook centres on $53.82, within a $40.87 to $76.04 range. That is up +32% on the projected 2027 average. That marks a +77% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, TECX could reach as high as $101.36, with a base case around $69.54 and support toward $51.45 — roughly +129% from $30.43. Momentum favours further upside here.
Expect TECX to range from $61.81 to $127.96 through 2030. The $85.52 average target implies a +181% move from current prices. That is up +23% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The TECX price prediction for 2031 points to an average of $106.39 (low $75.29, high $162.90) — a potential gain of +250% on today's $30.43. Momentum favours further upside here.
In 2032, TECX is projected to trade between $75.95 and $171.12, averaging $109.48 — a potential gain of +260% from today's $30.43. That is up +3% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Tectonic Therapeutic, Inc.'s 2033 outlook centres on $117.60, within a $80.06 to $187.27 range. That is up +7% on the projected 2032 average. That marks a +286% change versus current levels. Momentum favours further upside here.
By 2034, TECX could reach as high as $229.18, with a base case around $141.47 and support toward $94.61 — roughly +365% from $30.43. Buyers look set to stay in control over this stretch.
Expect TECX to range from $108.14 to $270.78 through 2035. The $164.50 average target implies a +441% move from current prices. That is up +16% on the projected 2034 average. Momentum favours further upside here.
The TECX price prediction for 2040 points to an average of $277.13 (low $168.42, high $487.59) — a potential gain of +811% on today's $30.43. Buyers look set to stay in control over this stretch.
In 2050, TECX is projected to trade between $388.22 and $1,420.80, averaging $733.08 — a potential gain of +23.1x from today's $30.43. That is up +165% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in TECX today (≈ 32.862307 TECX) could be worth
$24,090.75
+$23,090.75 (+2309%) by 2050 · US Dollar
Based on the average projected TECX price of $733.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TECXwould be worth at today's price.
$1,000 invested in TECX on May 27, 2025 (≈ 46.403714 TECX) would be worth
$1,412.07
+$412.07 (+41.2%) today · 1.41× · US Dollar
Based on a TECX entry price of $21.55 vs. today's $30.43.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $28.84 | $1,055.13 | +5.5% |
| 1 month ago | $28.75 | $1,058.43 | +5.8% |
| 3 months ago | $23.93 | $1,271.63 | +27.2% |
| 6 months ago | $21.44 | $1,419.31 | +41.9% |
| 1 year ago | $21.55 | $1,412.07 | +41.2% |
| All time (5.0y) ago | $109.56 | $277.75 | -72.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TECX forecast.
Our base-case forecast reaches $61.00 around 2029.
Implied market cap at $61.00: $1.15B
The multi-year forecast shows a persistent bullish trajectory across the years, with rising averages and expanding price potential.
Key yearly averages begin with 2026 at $29.12 and move to 2027 at $38.62, 2028 at $49.58, and 2029 at $63.96, followed by 2030 at $79.11 and 2031 at $97.01. The forecast also shows 2032 at $98.76 and 2033 at $105.76, continuing higher into 2034 at $125.73 and 2035 at $145.25, with cumulative upside implied by the sequence.
In the deeper horizon, 2040 is projected at an average of $240.03 and 2050 at $632.45, with max values up to $428.33 in 2040 and $1,246.24 in 2050. ROI percentages rise from 171.7% in 2030 to 724.3% in 2040 and 2,071.9% in 2050, all bearing a bullish sentiment.
These figures imply meaningful upside from current levels, though they are estimates and not guarantees, and are subject to market and sector dynamics along with company-specific outcomes.
Tap a question to reveal the answer.
2030 avg $79.11; min $56.68; max $119.52; ROI 171.7%; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages (2027 $38.62, 2028 $49.58, 2029 $63.96, 2030 $79.11, 2040 $240.03, 2050 $632.45) and ROI rising to 2071.9% by 2050.
Yes. The max in 2030 is $119.52 and the max in 2031 is $150.08, indicating the $100 level is within the forecast upside.
Current price is $29.12 and market capitalization is $549.47M; the stock ranks 2969 by market cap.
2040 min $143.24; avg $240.03; max $428.33; ROI 724.3%; sentiment BULLISH.
Tectonic Therapeutic, Inc. Community Discussion
0Share your Tectonic Therapeutic, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.